Accepted: February 23, 2010
Metformin enhances insulin sensitivity by suppressing hepatic gluconeogenesis and improving peripheral glucose uptake, reducing hyperinsulinemia and downstream ovarian androgen production ( The extent of weight loss observed with GLP-1 receptor agonists, especially in combination with metformin, is clinically relevant in the context of PCOS, a condition in which insulin resistance, central obesity, and metabolic dysfunction contribute to eventual infertility and long-term cardiometabolic risk ( Given the heterogeneity of PCOS phenotypes, a personalized, combination-based therapeutic approach may optimize outcomes beyond a uniform treatment model
et al., Verschiedenen pharmakologischen Angriffspunkte der beiden Substanzklassen in Abb.1, J Cardiovasc Pharmacal Ther 2019 Sep
Cannot redeclare control with same name "grid_1_qv_cta_style_tabs"
retail value hit $12.5 billion in 2012, jumping up 56% from 2006 to 2012